SCHEMBL7400231

SCHEMBL7400231

CC(CC(=O)c1cccc(Cl)c1)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ERCC5 P28715 1/20 0.55
FEN1 P39748 1/20 0.55
PARP1 P09874 1/20 0.47
HPGD P15428 2/20 0.47
SLC6A2 P23975 4/20 0.47
SLC6A3 Q01959 3/20 0.47
CHRNA1 P02708 1/20 0.47
CHRNG P07510 1/20 0.47
ITGA5 P08648 1/20 0.47
CHRNB1 P11230 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
SLC6A4 P31645 1/20 0.47
CHRNA3 P32297 1/20 0.47
CYP2C19 P33261 1/20 0.47
HRH1 P35367 1/20 0.47
CHRNA7 P36544 1/20 0.47
OPRK1 P41145 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13647196 0.85 ERCC5 (0.56) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL27965528 0.84 MEN1 (0.47) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL19984713 0.83 ERCC5 (0.54) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL728409 0.83 KMO (0.66) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL7406071 0.83 KMO (0.66) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL3675550 0.83 KMO (0.66) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL135355 0.81 L3MBTL1 (0.66) MEN1KMT2AHPGDALDH1A1SMN1; SMN2
SCHEMBL7799511 0.81 KMO (0.65) MEN1KMT2AERCC5FEN1PARP1
SCHEMBL7400747 0.81 CES2 (0.50) MEN1KMT2APARP1HPGDSLC6A2
SCHEMBL7799514 0.81 KMO (0.65) MEN1KMT2AERCC5FEN1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323240-B1 HALOGENATED DERIVATIVES AS ENZYME INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 2001-11-27 US disclosed
EP-0858443-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1998-08-19 EP disclosed
WO-1997017317-A1 4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1997-05-15 WO disclosed
EP-0115133-B1 SPIRO-3-HETERO-AZOLONES FOR TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1989-01-25 EP disclosed
US-4556670-A Spiro-3-hetero-azolones for treatment of diabetic complications PFIZER INC. (US) 1985-12-03 US disclosed
EP-0115133-A1 Spiro-3-hetero-azolones for treatment of diabetic complications PFIZER INC. (US) 1984-08-08 EP disclosed
EP-0010347-B1 NOVEL SUBSTITUTED OMEGA-AROYL(PROPIONYL OR BUTYRYL)-L-PROLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION AMERICAN CYANAMID COMPANY (US) 1983-11-09 EP disclosed
US-4226775-A HYPOTENSIVE AGENTS AMERICAN CYANAMID COMPANY (US) 1980-10-07 US disclosed
EP-0010347-A1 Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation AMERICAN CYANAMID COMPANY (US) 1980-04-30 EP disclosed
US-4112095-A 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents AMERICAN CYANAMID COMPANY (US) 1978-09-05 US disclosed